Nasal moisturizers
This article was originally published in The Tan Sheet
Executive Summary
Nasal moisturizers should be removed from FDA's OTC product review and regulated as cosmetics, law firm Kirkpatrick & Lockhart (Washington, D.C.) maintains in comments to FDA. Claims that the products provide moisture for inflamed nasal membranes due to colds "is not indicating a treatment for the cold, or other specific disease, nor is it claiming to mitigate or cure that disease," lawyers assert. The comments were submitted in response to FDA's call for data on unreviewed drug products as part of the OTC safety review (1"The Tan Sheet" Jan. 5, 2004, p. 11)...